Takeda Pharmaceutical Company Limited

TSE:4502 Rapport sur les actions

Capitalisation boursière : JP¥6.9t

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Takeda Pharmaceutical Gestion

Gestion contrôle des critères 2/4

Takeda Pharmaceutical's CEO is Christophe Weber, appointed in Jun 2014, has a tenure of 10.17 years. total yearly compensation is ¥2.08B, comprised of 15.2% salary and 84.8% bonuses, including company stock and options. directly owns 0.05% of the company’s shares, worth ¥3.43B. The average tenure of the management team and the board of directors is 6.9 years and 8.2 years respectively.

Informations clés

Christophe Weber

Directeur général

JP¥2.1b

Rémunération totale

Pourcentage du salaire du PDG15.2%
Durée du mandat du directeur général10.2yrs
Propriété du PDG0.05%
Durée moyenne d'occupation des postes de direction6.9yrs
Durée moyenne du mandat des membres du conseil d'administration8.2yrs

Mises à jour récentes de la gestion

Recent updates

Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's

Aug 08
Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's

Earnings Beat: Takeda Pharmaceutical Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Aug 02
Earnings Beat: Takeda Pharmaceutical Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Takeda Pharmaceutical (TSE:4502) Is Increasing Its Dividend To ¥98.00

Jul 25
Takeda Pharmaceutical (TSE:4502) Is Increasing Its Dividend To ¥98.00

Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's

Jul 11
Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's

Takeda Pharmaceutical Company Limited (TSE:4502) Yearly Results: Here's What Analysts Are Forecasting For This Year

Jun 30
Takeda Pharmaceutical Company Limited (TSE:4502) Yearly Results: Here's What Analysts Are Forecasting For This Year

Takeda Pharmaceutical (TSE:4502) Takes On Some Risk With Its Use Of Debt

Jun 11
Takeda Pharmaceutical (TSE:4502) Takes On Some Risk With Its Use Of Debt

Some Investors May Be Willing To Look Past Takeda Pharmaceutical's (TSE:4502) Soft Earnings

May 21
Some Investors May Be Willing To Look Past Takeda Pharmaceutical's (TSE:4502) Soft Earnings

Takeda Pharmaceutical Company Limited Just Recorded A 6.0% EPS Beat: Here's What Analysts Are Forecasting Next

May 12
Takeda Pharmaceutical Company Limited Just Recorded A 6.0% EPS Beat: Here's What Analysts Are Forecasting Next

Takeda Pharmaceutical (TSE:4502) Is Due To Pay A Dividend Of ¥94.00

Mar 28
Takeda Pharmaceutical (TSE:4502) Is Due To Pay A Dividend Of ¥94.00

Takeda Pharmaceutical (TSE:4502) Has Announced A Dividend Of ¥94.00

Mar 13
Takeda Pharmaceutical (TSE:4502) Has Announced A Dividend Of ¥94.00

Takeda Pharmaceutical (TSE:4502) Will Pay A Dividend Of ¥94.00

Feb 26
Takeda Pharmaceutical (TSE:4502) Will Pay A Dividend Of ¥94.00

Analyse de la rémunération des PDG

Comment la rémunération de Christophe Weber a-t-elle évolué par rapport aux bénéfices de Takeda Pharmaceutical?
DateRémunération totaleSalaireBénéfices de l'entreprise
Jun 30 2024n/an/a

JP¥150b

Mar 31 2024JP¥2bJP¥317m

JP¥144b

Dec 31 2023n/an/a

JP¥178b

Sep 30 2023n/an/a

JP¥192b

Jun 30 2023n/an/a

JP¥301b

Mar 31 2023JP¥2bJP¥295m

JP¥317b

Dec 31 2022n/an/a

JP¥275b

Sep 30 2022n/an/a

JP¥213b

Jun 30 2022n/an/a

JP¥197b

Mar 31 2022JP¥2bJP¥281m

JP¥230b

Dec 31 2021n/an/a

JP¥439b

Sep 30 2021n/an/a

JP¥473b

Jun 30 2021n/an/a

JP¥431b

Mar 31 2021JP¥2bJP¥267m

JP¥376b

Dec 31 2020n/an/a

JP¥181b

Sep 30 2020n/an/a

JP¥56b

Jun 30 2020n/an/a

JP¥120b

Mar 31 2020JP¥2bJP¥273m

JP¥44b

Dec 31 2019n/an/a

JP¥13b

Sep 30 2019n/an/a

JP¥83b

Jun 30 2019n/an/a

JP¥64b

Mar 31 2019JP¥2bJP¥269m

JP¥135b

Dec 31 2018n/an/a

JP¥110b

Sep 30 2018n/an/a

JP¥141b

Jun 30 2018n/an/a

JP¥120b

Mar 31 2018JP¥1bJP¥254m

JP¥187b

Rémunération vs marché: Christophe's total compensation ($USD14.22M) is above average for companies of similar size in the JP market ($USD1.64M).

Rémunération et revenus: Christophe's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.

PDG

Christophe Weber (58 yo)

10.2yrs

Titularisation

JP¥2,083,000,000

Compensation

Mr. Christophe Weber has been the President and Chief Executive Officer of Takeda Pharmaceutical Company Limited since June 27, 2014 and April 2015 respectively and served as its Chief Operating Officer fr...

Équipe de direction

NomPositionTitularisationCompensationPropriété
Christophe Weber
President10.2yrsJP¥2.08b0.050%
¥ 3.4b
Seigo Izumo
Chair of Management Boardno datapas de donnéespas de données
Milano Furuta
CFO & Directorless than a yearpas de données0.00083%
¥ 57.4m
Haruhiko Hirate
Member of Management Boardno datapas de donnéespas de données
Salvatore Alesci
Member of Management Board and Head of R&D Global Science & Biomedical Policyno datapas de donnéespas de données
Norimasa Takeda
Chief Accounting Officer & Corporate Controllerno datapas de donnéespas de données
Iwaaki Taniguchi
Senior Vice President of Corporate Finance & Controlling Department11.4yrspas de donnéespas de données
Gabriele Ricci
Chief Data & Technology Officer2.5yrspas de donnéespas de données
Christopher David O'Reilly
Global Head of Investor Relations & Global Finance3.9yrspas de donnéespas de données
Yoshihiro Nakagawa
Global General Counsel9.8yrspas de donnéespas de données
Mwana Lugogo
Chief Ethics & Compliance Officer9.8yrspas de donnéespas de données
Lauren Duprey
Chief Human Resources Officer3.6yrspas de donnéespas de données

6.9yrs

Durée moyenne de l'emploi

51.5yo

Âge moyen

Gestion expérimentée: 4502's management team is seasoned and experienced (6.9 years average tenure).

Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Christophe Weber
President10.2yrsJP¥2.08b0.050%
¥ 3.4b
Milano Furuta
CFO & Directorno datapas de données0.00083%
¥ 57.4m
Andrew S. Plump
President of Research & Development and Representative Director9.2yrsJP¥972.00m0.0087%
¥ 603.8m
John M. Maraganore
Independent External Director2.2yrsJP¥32.00mpas de données
Steven S. Gillis
Independent External Director5.6yrsJP¥44.00m0.00026%
¥ 18.0m
Emiko Higashi
Independent External Director8.2yrsJP¥49.00m0.00016%
¥ 11.1m
Yoshiaki Fujimori
Independent External Director8.2yrsJP¥40.00m0.00079%
¥ 54.6m
Ian T. Clark
Independent External Director5.6yrsJP¥44.00m0.000070%
¥ 4.8m
Jean-Luc Butel
Independent External Director5.2yrsJP¥38.00mpas de données
Michel Orsinger
Independent External Director8.2yrsJP¥46.00mpas de données
Masami Iijima
Independent External Chair3.2yrsJP¥43.00m0.000020%
¥ 1.4m
Koji Hatsukawa
Independent External Director8.2yrsJP¥43.00m0.00063%
¥ 43.6m

8.2yrs

Durée moyenne de l'emploi

66.5yo

Âge moyen

Conseil d'administration expérimenté: 4502's board of directors are considered experienced (8.2 years average tenure).